AVITA Medical Inc (RCEL)
13.34
+0.47
(+3.65%)
USD |
NASDAQ |
Nov 22, 16:00
13.32
-0.02
(-0.15%)
After-Hours: 20:00
AVITA Medical Enterprise Value: 347.88M for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 347.88M |
| November 21, 2024 | 335.56M |
| November 20, 2024 | 340.28M |
| November 19, 2024 | 337.92M |
| November 18, 2024 | 324.03M |
| November 15, 2024 | 311.44M |
| November 14, 2024 | 327.96M |
| November 13, 2024 | 335.56M |
| November 12, 2024 | 330.06M |
| November 11, 2024 | 318.00M |
| November 08, 2024 | 311.44M |
| November 07, 2024 | 323.24M |
| November 06, 2024 | 317.73M |
| November 05, 2024 | 297.02M |
| November 04, 2024 | 290.99M |
| November 01, 2024 | 268.18M |
| October 31, 2024 | 262.94M |
| October 30, 2024 | 270.54M |
| October 29, 2024 | 268.97M |
| October 28, 2024 | 273.95M |
| October 25, 2024 | 263.73M |
| October 24, 2024 | 263.73M |
| October 23, 2024 | 270.54M |
| October 22, 2024 | 277.10M |
| October 21, 2024 | 273.95M |
| Date | Value |
|---|---|
| October 18, 2024 | 276.84M |
| October 17, 2024 | 272.64M |
| October 16, 2024 | 278.41M |
| October 15, 2024 | 271.33M |
| October 14, 2024 | 271.07M |
| October 11, 2024 | 268.45M |
| October 10, 2024 | 257.43M |
| October 09, 2024 | 263.46M |
| October 08, 2024 | 263.99M |
| October 07, 2024 | 272.38M |
| October 04, 2024 | 281.82M |
| October 03, 2024 | 281.03M |
| October 02, 2024 | 286.80M |
| October 01, 2024 | 274.74M |
| September 30, 2024 | 279.19M |
| September 27, 2024 | 266.06M |
| September 26, 2024 | 261.90M |
| September 25, 2024 | 257.49M |
| September 24, 2024 | 261.64M |
| September 23, 2024 | 261.38M |
| September 20, 2024 | 269.44M |
| September 19, 2024 | 268.40M |
| September 18, 2024 | 257.75M |
| September 17, 2024 | 253.59M |
| September 16, 2024 | 253.59M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
29.23M
Minimum
Oct 14 2022
23.29B
Maximum
Feb 19 2020
1.845B
Average
321.11M
Median
Jun 09 2021
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | -31.63M |
| Retractable Technologies Inc | -16.44M |
| InfuSystems Holdings Inc | 225.98M |
| Xtant Medical Holdings Inc | 83.10M |
| Catheter Precision Inc | 3.859M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.20M |
| Revenue (Quarterly) | 19.55M |
| Total Expenses (Quarterly) | 33.35M |
| EPS Diluted (Quarterly) | -0.62 |
| Gross Profit Margin (Quarterly) | 83.68% |
| Profit Margin (Quarterly) | -82.91% |
| Earnings Yield | -16.72% |
| Normalized Earnings Yield | -16.72 |